Dose Escalation and Dose Expansion Study of CPO-100 in Patients With Advanced Solid Tumors
Conjupro Biotherapeutics, Inc.
Conjupro Biotherapeutics, Inc.
Sotio Biotech Inc.
Genmab
Pfizer
Pheon Therapeutics
Ocellaris Pharma, Inc.
Seagen Inc.
Sotio Biotech Inc.
Bolt Biotherapeutics, Inc.
Shasqi, Inc.
Alaunos Therapeutics
Incyte Corporation
Actym Therapeutics, Inc.
NiKang Therapeutics, Inc.
Pfizer
Novartis
Alaunos Therapeutics
Numab Therapeutics AG
University of Virginia
Lyell Immunopharma, Inc.
Lyell Immunopharma, Inc.
M.D. Anderson Cancer Center
Numab Therapeutics AG
NextCure, Inc.
Elevation Oncology
Mayo Clinic
Seagen Inc.
Seagen Inc.
Seagen Inc.
Deciphera Pharmaceuticals, LLC
Aminex Therapeutics, Inc.
Novartis
Rain Oncology Inc
NantCell, Inc.
NantCell, Inc.
Pfizer
Hoffmann-La Roche
ADC Therapeutics S.A.
ABM Therapeutics Corporation
Pfizer
Ikena Oncology
Mersana Therapeutics
Gilead Sciences
CytomX Therapeutics
Atreca, Inc.
Fusion Pharmaceuticals Inc.
SCRI Development Innovations, LLC
pharmaand GmbH
Fate Therapeutics
Hoffmann-La Roche